New research suggests that an existing medication commonly prescribed for constipation could offer a breakthrough in treating cognitive symptoms associated with depression. In a targeted clinical trial, researchers found that the drug prucalopride may help clear the cognitive impairment often referred to as "brain fog."
Improved Cognitive Performance
During the study, participants with a history of depression who were administered prucalopride for approximately one week showed marked improvements in several key areas. Compared to a control group receiving a placebo, those taking the medication performed significantly better on standardized tests measuring memory, attention span, and processing speed.
The Serotonin Connection
The drug works by targeting a specific serotonin receptor that is present in both the gastrointestinal tract and the brain. This dual presence explains why a gut-focused medication can influence neurological functions. Importantly, researchers reported that the treatment was well-tolerated, with no significant side effects observed during the trial period. This discovery opens the door for further research into repurposed medications to treat the lingering cognitive effects of mental health disorders.
